Community/Retail

Downing Labs, a retail pharmacy based in Texas, has issued a voluntary recall of all lots of sterile products.

Contrary to the findings of a previous study, patients with atrial fibrillation who are admitted to the hospital on the weekend face no greater risks than those admitted on a weekday.

Students from Concordia University School of Pharmacy and Texas Tech School of Pharmacy recently collected unwanted and expired medications in their respective communities.

Misinformed patients may be inadvertently harming themselves with medications.

Amneal Pharmaceuticals recently won the award for "Company of the Year, Americas" at the 2015 Global Generics and Biosimilars Awards held in Madrid, Spain.

Medicare beneficiaries currently choosing a 2016 drug plan may be relying on inaccurate data posted on the Medicare Plan Finder website, and pending regulatory guidance could fix this for future years and increase transparency, 11 U.S. lawmakers said in a bipartisan letter to the Centers for Medicare & Medicaid Services.

MinuteClinic, the walk-in medical clinic of CVS Health, has opened its 1,000th MinuteClinic location nationwide.

The FDA has approved Relypsa's patiromer (Veltassa) for the treatment of hyperkalemia, a serious condition in which there is an elevated level of potassium in a patient's blood.

James Schiffer, RPh, associate at Allegaert Berger & Vogel LLC, talks about the 18 times he was burglarized over the course of his career.

Allergan has launched an OTC artificial tear product for dry eyes.

Donnie Calhoun, RPh, PD, National Community Pharmacists Association (NCPA) Foundation vice president, discusses the integrated resource and support center and how it can help pharmacists with their contingency planning.

One of the largest pharmacies damaged during the Freddie Gray riots in Baltimore has reopened.

Cardiac experts and public policy makers have growing concerns about heart failure, which is increasing in prevalence and costing billions of dollars a year.

A pharmacy in Georgia has the remedy for everything: headaches, stomach pain, and even monsters.

ASHP today joined President Barack Obama in announcing new efforts to address the prescription drug abuse and heroin epidemic.

There has been a lot of talk about all of the amazing things probiotics can offer.

Jesse McCullough, a registered pharmacist and Rite Aid's director of field clinical services, has testified before the US House of Representatives Committee on Energy and Commerce Subcommittee on Health during a recent hearing.

Pharmacy staff across all care settings can make Pharmacy Week a success.

Pharmaceutical manufacturers are pretty good at finding new ways to make a profit on their drugs.

Ron Lanton, of True North Political Solutions, interviews Jennifer Mallon, vice president and general counsel of the National Community Pharmacists Association, on the health policy check-up segment.

Medicare can achieve the dual goals of better health outcomes for the program's beneficiaries and at lower overall costs if the medication therapy management services of community pharmacists are better utilized, the National Community Pharmacists Association said today in comments submitted to a congressional committee.

A little more than a year has passed since the Drug Enforcement Administration (DEA) announced that pharmacies could collect and destroy unused prescription drugs, but what kind of impact has this regulation made?

Now through February, patients can stop by any Reasor's location and receive their 2015-2016 flu shot, administered by a vaccination-trained pharmacist.

The FDA has rejected Pfizer's supplemental new drug application to expand the use of tofacitinib citrate.

Neil Friedman, COO at Bodimetrics, describes the key functions and features of the Bodimetrics Performance Monitor.

James Schiffer, RPh, associate at Allegaert Berger & Vogel LLC, discusses why DEA audits of pharmacies may be increasing.

Iris Gill recently celebrated her 4th birthday with a party completely inspired by her favorite pharmacy.

The FDA today approved Tris Pharma's extended-release amphetamine oral suspension (Dyanavel XR) for the treatment of ADHD in children aged 6 years and older.